• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NUVECTRA CORPORATION ALGOVITA SPINAL CORD STIMULATION; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NUVECTRA CORPORATION ALGOVITA SPINAL CORD STIMULATION; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF) Back to Search Results
Model Number 1121-60T
Device Problems Device Issue (2379); Device Operational Issue (2914); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Scar Tissue (2060)
Event Date 12/21/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial: device requested and to be received by manufacturer for evaluation.The device history reviews (dhrs) were reviewed for final pack lot w358291 and sterile pack lot w3298625 and there were no anomalies noted.Root cause for this event could not be determined as no device has been returned for evaluation and reviewing of the manufacturing records did not reveal any applicable discrepancies.No malfunctioned of the device could be confirmed.
 
Event Description
It was reported on 21 december 2016 that a patient had undergone a four day trial period for spinal cord stimulation.The physician had difficulty placing the bilateral trial leads initially.The patient presented with scar tissue/adhesions.At the end of the trial, the first trial lead was removed without difficulty.The second trial was removed with force.A portion of the distal end of the lead remained.The remainder was removed through a cut-down without complications.
 
Manufacturer Narrative
Date of this report 01/17/2017 updated to 02/16/2017.Date returned to manufacturer updated to 01/09/2017.Date received by manufacturer (b)(6) 2016 updated to 02/15/2017.Type of report "initial" updated to "follow-up." if follow-up, what type updated to additional information and device evaluation.Device evaluated by manufacturer "no" updated to "yes." (b)(4).Visual inspection showed the first trial lead body was partially separated from the distal end of the lead at the contacts/electrodes.The second trial lead was separated in two pieces, consisting of the distal end of the lead with contacts and one piece with contacts remaining at the proximal end of the lead.No evidence could be determined to be inherently wrong with the leads themselves that would have been present prior to the lead extractions during the trial period.
 
Event Description
It was reported on (b)(6) 2016 that a patient had undergone a four day trial period for spinal cord stimulation.The physician had difficulty placing the bilateral trial leads initially.The patient presented with scar tissue/adhesions.At the end of the trial, the first trial lead was removed without difficulty.The second trial was removed with force.A portion of the distal end of the lead remained.The remainder was removed through a cut-down without complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALGOVITA SPINAL CORD STIMULATION
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF)
Manufacturer (Section D)
NUVECTRA CORPORATION
10675 naples street ne
blaine 55499
Manufacturer (Section G)
NUVECTRA CORPORATION
10675 naples street ne
blaine 55449
Manufacturer Contact
amy parker
10675 naples street ne
blaine 55449
7634047531
MDR Report Key6258606
MDR Text Key65026467
Report Number3010309840-2016-00014
Device Sequence Number1
Product Code LGW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/22/2017
Device Model Number1121-60T
Device Catalogue Number1121-60T
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/09/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/22/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
-
-